| Stage | RDNT | % of rev | DGX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $623M | 100.00% | $3.1B | 100.00% | DGX ×4.97 |
| Gross profit | $88M | 14.14% | $1.0B | 33.65% | DGX +19.5pp |
| Operating income | $39M | 6.34% | $479M | 15.47% | DGX +9.1pp |
| Pre-tax income | $27M | 4.27% | $416M | 13.43% | DGX +9.2pp |
| Net income | $20M | 3.25% | $326M | 10.53% | DGX +7.3pp |
| Stage | RDNT | DGX | Gap · A − B |
|---|---|---|---|
| Revenue | $623M100.00% | $3.1B100.00% | DGX ×4.97 |
| Gross profit | 14.14%$88M | 33.65%$1.0B | DGX +19.5pp |
| Operating income | 6.34%$39M | 15.47%$479M | DGX +9.1pp |
| Pre-tax income | 4.27%$27M | 13.43%$416M | DGX +9.2pp |
| Net income |
| 3.25%$20M |
| 10.53%$326M |
| DGX +7.3pp |
No shared counterparties.